ContextVision presents Q2 2013 report

Q2 HIGHLIGHTS

  • New major ultrasound customer signed
  • ContextVision wins important court ruling regarding patent litigation against Sapheneia.

Q2 FINANCIAL DATA

  • Sales of 14.0 MSEK (16.0)
  • Operating result of -1.9 MSEK (-3.0) and operating margin of -13.3% (-18.7%).
  • Earnings per share of -0,18 (-0,37) SEK

A video presentation by CEO Anita Tollstadius will be released on Friday, Aug 23:rd.

Please follow the link:

www.abiliteam.se/contextvisionQ22013

About Us

ContextVision is the leading independent developer in medical imaging enhancement, analysis and processing technologies, serving leading OEMs and distributors for more than 25 years. ContextVision’s embedded imaging software is relied upon daily by thousands of users around the globe. ContextVision’s patented GOP algorithm allows unprecedented image quality to be achieved by simultaneously enhancing fine structure while reducing noise and speckle across MRI, X-Ray, Ultrasound, CT, and IR. ContextVision’s technology enables the company’s customers to provide superior digital imaging quality to hospitals and clinicians. Such solutions promise more rapid and accurate diagnoses, reduced operator eye fatigue, and ultimately, a greater return-on-investment for medical imaging users. For more information, please visit www.contextvision.com.

Subscribe

Documents & Links